A regulatory filing disclosed that Quest Diagnostics has reached a deal with Goldman Sachs to buy back its company shares worth about $450 million. The transaction is set to be finalized during the third quarter of this year.
Quest Diagnostics signs $450M share-repurchase agreement
SmartBrief Job Listings for Health Care
|Sr. Regulatory Specialist, Biotech Center of Expertise||
BASF, The Chemical Co.
|San Diego, CA|
|Director of Clinical Research||
Regenesis Biomedical, Inc.
Meridian Health Plan
|Assistant Vice President - Dental Director||